Mbi-4 - Compound Search

Lansoprazole Imp. E (EP); Rabeprazole Sodium Imp. F (EP); Rabeprazole Imp. F (EP); Rabeprazole USP Related Compound C; Rabeprazole USP RC C; 1,3-Dihydro-2H-benzimidazole-2-thione; 2-Benzimidazolethiol (8CI); 2-Benzimidazolinethione (6CI,7CI); 1,3-Dihydro-2H-benzoimidazole-2-thione; 1H-Benzimidazole-2-thiol; 1H-Benzo[d]imidazole-2(3H)-thione; 1H-Benzo[d]imidazole-2-thiol; 2,3-Dihydro-1H-benzimidazole-2-thione; 2-Benzimidazolethione; 2-Mercapto-1H-benzimidazole; 2-Mercaptobenzimidazole; 2-Sulfhydrylbenzimidazole; 2-Thiobenzimidazole; AO-MB; ASM MB; Antage MB; Antigene MB; Antioxidant MB; Antioxidant MB/K; Benzimidazolin-2-thione; Curekind MBI/B; G 580; MB; MB/K; MBI 80; NSC 186246; NSC 21414; Nocrac MB; Nonflex MB; Permanax 21; Rhenogran MBI 80; Sandant MB; Sumilizer MB; Vulkanox MB; Vulkanox MBI; Vulkanox MG; o-Phenylenethiourea; Rabeprazole Related Compound C; Lansoprazole Impurity E; Ra CAS 583-39-1 PubChem CID 707035

S=c1[nH]c2ccccc2[nH]1

(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide CAS 204248-78-2 PubChem CID 16131445

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O

(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide;pentahydrochloride CAS 269062-93-3 PubChem CID 16131446

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O.Cl.Cl.Cl.Cl.Cl

1,4-|A-D-Mannobiose; (2R,3S,4R,5S,6R)-6-(hydroxymethyl)-5-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol/(2S,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal CAS 14417-51-7 PubChem CID 152109

OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@H](O)C(O)O[C@@H]2CO)[C@@H](O)[C@@H](O)[C@@H]1O

1,2,3,4,4abeta,5,7,7abeta-Octahydro-2-imino-3-methyl-4-oxo-6-(4-methyl-6-methoxy-5-fluoropyrimidine-2-yl)-7a-(2,4-difluorophenyl)-6H-pyrrolo[3,4-d]pyrimidine PubChem CID 44467360

COc1nc(N2C[C@H]3C(=O)N(C)C(N)=N[C@@]3(c3ccc(F)cc3F)C2)nc(C)c1F

2-(N-hydroxyimino)-1-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethan-1-one CAS 143797-41-5 PubChem CID 6443357

CC(C)=CCOc1ccc(C(=O)/C=N/O)cc1

N,N-dimethyl-4-[(E)-2-(3-methyl-1,3-benzoxazol-3-ium-2-yl)ethenyl]aniline;iodide CAS 6285-94-5 PubChem CID 17961165

CN(C)c1ccc(/C=C/c2oc3ccccc3[n+]2C)cc1.[I-]

3-[(4-bromophenyl)carbonylamino]-4-[4-(5-chloranyl-2-methyl-phenyl)piperazin-1-yl]benzoic acid PubChem CID 169488756

Cc1ccc(Cl)cc1N1CCN(c2ccc(C(=O)O)cc2NC(=O)c2ccc(Br)cc2)CC1

BSP-C705 series (lipopeptide antibiotics, Gram-positive bacterial infections), BioSource Pharm CAS 64205-15-8 PubChem CID 57416885

CC(C)(C)OC(=O)ON1C(=O)C2C(C1=O)[C@H]1C=C[C@@H]2C1

Compound Database